Variants of HSD11B2 gene in hypertensive disorders of pregnancy

References

• Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33:130–7
   PubMed Web of Science ®Google Scholar
• Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol 2012;36:56–9
   PubMed Web of Science ®Google Scholar
• Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066–74
   PubMed Web of Science ®Google Scholar
• Callaghan WM. Overview of maternal mortality in the United States. Semin Perinatol 2012;36:2–6
   PubMed Web of Science ®Google Scholar
• Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol Mech Dis 2010;5:173–92
   PubMed Web of Science ®Google Scholar
• Bezerra PCFM, Leão MD, Queiroz JW, et al. Family history of hypertension as an important risk factor for the development of severe preeclampsia. Acta Obstet Gynecol Scand 2010;89:612–17
   PubMed Web of Science ®Google Scholar
• Skjaerven R, Vatten LJ, Wilcox AJ, et al. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ 2005;331:877
   PubMed Web of Science ®Google Scholar
• Seremak-Mrozikiewicz A, Drews K. Genetic background of preeclampsia. Ginekol Pol 2007;78:802–6
   PubMedGoogle Scholar
• Kosicka K, Siemiątkowska A, Główka FK. 11β-Hydroxysteroid dehydrogenase 2 in preeclampsia. Int J Endocrinol 2016;2016:5279462
   PubMed Web of Science ®Google Scholar
• Harris A, Seckl J. Glucocorticoids, prenatal stress and the programming of disease. Horm Behav 2011;59:279–89
   PubMed Web of Science ®Google Scholar
• Mukherjee S, James JL, Thilaganathan B, et al. Elevated glucocorticoid metabolism in placental tissue from first trimester pregnancies at increased risk of pre-eclampsia. Placenta 2011;32:687–93
   PubMed Web of Science ®Google Scholar
• Reynolds RM. Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis – 2012 Curt Richter Award Winner. Psychoneuroendocrinology 2013;38:1–11
   PubMed Web of Science ®Google Scholar
• Kosicka K, Główka FK, Kośla A, et al. Glucocorticoids action in etiology of hypertension. Arter Hypertens 2010;14:208–15
   Google Scholar
• Romer TE, Litwin M, Małunowicz E. Apparent mineralocorticoid excess – AME. Endokrynol Pol 2004;55:463–70
   Google Scholar
• World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Geneva: World Health Organization; 2011
   Google Scholar
• Shimodaira M, Nakayama T, Sato I, et al. Glucocorticoid synthesis-related genes: HSD11B1 and HSD11B2 in hypertensive disorders in pregnancy. Gynecol Endocrinol 2013;29:657–61
   PubMed Web of Science ®Google Scholar
• Kosicka K, Cymerys M, Majchrzak-Celińska A, et al. 11β-Hydroxysteroid dehydrogenase type 2 in hypertension: comparison of phenotype and genotype analysis. J Hum Hypertens 2013;27:510–5
   PubMed Web of Science ®Google Scholar
• Brand E, Kato N, Chatelain N, et al. Structural analysis and evaluation of the 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) gene in human essential hypertension. J Hypertens 1998;16:1627–33
   PubMed Web of Science ®Google Scholar
• Campino C, Quinteros H, Owen GI, et al. 11β-hydroxysteroid dehydrogenase type 2 polymorphisms and activity in a Chilean essential hypertensive and normotensive cohort. Am J Hypertens 2012;25:597–603
   PubMed Web of Science ®Google Scholar
• Mariniello B, Ronconi V, Sardu C, et al. Analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension. Am J Hypertens 2005;18:1091–8
   PubMed Web of Science ®Google Scholar
• Melander O, Orho-Melander M, Bengtsson K, et al. Association between a variant in the 11 beta-hydroxysteroid dehydrogenase type 2 gene and primary hypertension. J Hum Hypertens 2000;14:819–23
   PubMed Web of Science ®Google Scholar
• Poch E, González D, Giner V, et al. Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension 2001;38:1204–9
   PubMed Web of Science ®Google Scholar
• Smolenicka Z, Bach E, Schaer A, et al. A new polymorphic restriction site in the human 11 beta-hydroxysteroid dehydrogenase type 2 gene. J Clin Endocrinol Metab 1998;83:1814–17
   PubMed Web of Science ®Google Scholar
• Alikhani-Koopaei R, Fouladkou F, Frey FJ, et al. Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. J Clin Invest 2004;114:1146–57
   PubMed Web of Science ®Google Scholar
• Friso S, Pizzolo F, Choi S-W, et al. Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension. Atherosclerosis 2008;199:323–7
   PubMed Web of Science ®Google Scholar
• Marsit CJ, Maccani MA, Padbury JF, et al. Placental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome. PLoS One 2012;7:e33794
   PubMed Web of Science ®Google Scholar
• Zhao Y, Gong X, Chen L, et al. Site-specific methylation of placental HSD11B2 gene promoter is related to intrauterine growth restriction. Eur J Hum Genet 2014;22:734–40
   PubMed Web of Science ®Google Scholar
• Hogg K, Blair JD, McFadden DE, et al. Early onset pre-eclampsia is associated with altered DNA methylation of cortisol-signalling and steroidogenic genes in the placenta. PLoS One 2013;8:e62969
   PubMed Web of Science ®Google Scholar
• Green BB, Armstrong DA, Lesseur C, et al. The role of placental 11-beta hydroxysteroid dehydrogenase type 1 and type 2 methylation on gene expression and infant birth weight. Biol Reprod 2015;92:149
   PubMed Web of Science ®Google Scholar
• Hu W, Weng X, Dong M, et al. Alteration in methylation level at 11β-hydroxysteroid dehydrogenase type 2 gene promoter in infants born to preeclamptic women. BMC Genet 2014;15:96–101
   PubMed Web of Science ®Google Scholar